ABBVIE INC (1ABBV.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ABBV - US00287Y1091 - Common Stock
194.2 EUR
-6.8 (-3.38%)
Taking everything into account, 1ABBV scores 5 out of 10 in our fundamental rating. 1ABBV was compared to 81 industry peers in the Biotechnology industry. 1ABBV has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1ABBV is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
1ABBV had positive earnings in the past year.
1ABBV had a positive operating cash flow in the past year.
Each year in the past 5 years 1ABBV has been profitable.
Each year in the past 5 years 1ABBV had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 2.71%, 1ABBV is doing good in the industry, outperforming 76.62% of the companies in the same industry.
With an excellent Return On Invested Capital value of 13.81%, 1ABBV belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
1ABBV had an Average Return On Invested Capital over the past 3 years of 13.67%. This is in line with the industry average of 13.22%.
The last Return On Invested Capital (13.81%) for 1ABBV is above the 3 year average (13.67%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | N/A | ||
| ROIC | 13.81% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
1.3 Margins
1ABBV has a Profit Margin of 6.38%. This is amongst the best in the industry. 1ABBV outperforms 80.52% of its industry peers.
1ABBV's Profit Margin has declined in the last couple of years.
1ABBV has a Operating Margin of 31.27%. This is amongst the best in the industry. 1ABBV outperforms 90.91% of its industry peers.
1ABBV's Operating Margin has declined in the last couple of years.
1ABBV's Gross Margin of 70.93% is fine compared to the rest of the industry. 1ABBV outperforms 64.94% of its industry peers.
In the last couple of years the Gross Margin of 1ABBV has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.27% | ||
| PM (TTM) | 6.38% | ||
| GM | 70.93% |
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ABBV is creating some value.
1ABBV has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1ABBV has more shares outstanding
Compared to 1 year ago, 1ABBV has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.40 indicates that 1ABBV is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of 1ABBV (2.40) is better than 63.64% of its industry peers.
1ABBV has a debt to FCF ratio of 3.86. This is a good value and a sign of high solvency as 1ABBV would need 3.86 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.86, 1ABBV is in the better half of the industry, outperforming 79.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.86 | ||
| Altman-Z | 2.4 |
ROIC/WACC1.52
WACC9.09%
2.3 Liquidity
A Current Ratio of 0.74 indicates that 1ABBV may have some problems paying its short term obligations.
1ABBV has a worse Current ratio (0.74) than 76.62% of its industry peers.
A Quick Ratio of 0.61 indicates that 1ABBV may have some problems paying its short term obligations.
The Quick ratio of 1ABBV (0.61) is worse than 77.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.61 |
3. Growth
3.1 Past
The earnings per share for 1ABBV have decreased by -1.03% in the last year.
The Earnings Per Share has been growing slightly by 2.51% on average over the past years.
Looking at the last year, 1ABBV shows a small growth in Revenue. The Revenue has grown by 6.05% in the last year.
1ABBV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.11% yearly.
EPS 1Y (TTM)-1.03%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%12.08%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%6.65%
3.2 Future
1ABBV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.59% yearly.
Based on estimates for the next years, 1ABBV will show a small growth in Revenue. The Revenue will grow by 7.22% on average per year.
EPS Next Y6.19%
EPS Next 2Y19.88%
EPS Next 3Y16.85%
EPS Next 5Y13.59%
Revenue Next Year8.23%
Revenue Next 2Y8.64%
Revenue Next 3Y8.27%
Revenue Next 5Y7.22%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
1ABBV is valuated rather expensively with a Price/Earnings ratio of 21.29.
Based on the Price/Earnings ratio, 1ABBV is valued cheaper than 80.52% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.41, 1ABBV is valued at the same level.
1ABBV is valuated correctly with a Price/Forward Earnings ratio of 15.51.
Based on the Price/Forward Earnings ratio, 1ABBV is valued cheaply inside the industry as 87.01% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.40, 1ABBV is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.29 | ||
| Fwd PE | 15.51 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1ABBV is valued a bit cheaper than the industry average as 77.92% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, 1ABBV is valued cheaply inside the industry as 84.42% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.84 | ||
| EV/EBITDA | 17.28 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ABBV does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of 1ABBV may justify a higher PE ratio.
A more expensive valuation may be justified as 1ABBV's earnings are expected to grow with 16.85% in the coming years.
PEG (NY)3.44
PEG (5Y)8.48
EPS Next 2Y19.88%
EPS Next 3Y16.85%
5. Dividend
5.1 Amount
1ABBV has a Yearly Dividend Yield of 2.87%.
Compared to an average industry Dividend Yield of 10.20, 1ABBV pays a better dividend. On top of this 1ABBV pays more dividend than 94.81% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, 1ABBV pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.87% |
5.2 History
On average, the dividend of 1ABBV grows each year by 7.72%, which is quite nice.
Dividend Growth(5Y)7.72%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
304.54% of the earnings are spent on dividend by 1ABBV. This is not a sustainable payout ratio.
The dividend of 1ABBV is growing, but earnings are growing more, so the dividend growth is sustainable.
DP304.54%
EPS Next 2Y19.88%
EPS Next 3Y16.85%
BIT:1ABBV (12/1/2025, 7:00:00 PM)
194.2
-6.8 (-3.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners74.42%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap343.07B
Revenue(TTM)58.33B
Net Income(TTM)3.72B
Analysts79.46
Price Target197.82 (1.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.87% |
Yearly Dividend5.38
Dividend Growth(5Y)7.72%
DP304.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.04%
Min EPS beat(2)0.95%
Max EPS beat(2)1.14%
EPS beat(4)4
Avg EPS beat(4)0.75%
Min EPS beat(4)0.02%
Max EPS beat(4)1.14%
EPS beat(8)7
Avg EPS beat(8)0.76%
EPS beat(12)9
Avg EPS beat(12)0.46%
EPS beat(16)11
Avg EPS beat(16)0.4%
Revenue beat(2)2
Avg Revenue beat(2)0.93%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.23%
Revenue beat(4)2
Avg Revenue beat(4)0.24%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.36%
Revenue beat(12)5
Avg Revenue beat(12)-0.32%
Revenue beat(16)5
Avg Revenue beat(16)-0.81%
PT rev (1m)4.92%
PT rev (3m)5.18%
EPS NQ rev (1m)-45.1%
EPS NQ rev (3m)-44.14%
EPS NY rev (1m)-12.38%
EPS NY rev (3m)-13.98%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)1.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.29 | ||
| Fwd PE | 15.51 | ||
| P/S | 6.83 | ||
| P/FCF | 21.84 | ||
| P/OCF | 20.66 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.28 |
EPS(TTM)9.12
EY4.7%
EPS(NY)12.52
Fwd EY6.45%
FCF(TTM)8.89
FCFY4.58%
OCF(TTM)9.4
OCFY4.84%
SpS28.43
BVpS-0.09
TBVpS-45.26
PEG (NY)3.44
PEG (5Y)8.48
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | N/A | ||
| ROCE | 18.72% | ||
| ROIC | 13.81% | ||
| ROICexc | 14.74% | ||
| ROICexgc | 370.81% | ||
| OM | 31.27% | ||
| PM (TTM) | 6.38% | ||
| GM | 70.93% | ||
| FCFM | 31.27% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
ROICexc(3y)15.06%
ROICexc(5y)13.91%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.54%
ROCE(5y)16.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.81%
ROICexc growth 5Y-14.87%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.86 | ||
| Debt/EBITDA | 2.58 | ||
| Cap/Depr | 12.62% | ||
| Cap/Sales | 1.79% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.74% | ||
| Profit Quality | 489.9% | ||
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.61 | ||
| Altman-Z | 2.4 |
F-Score6
WACC9.09%
ROIC/WACC1.52
Cap/Depr(3y)9.59%
Cap/Depr(5y)10.06%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)361.43%
Profit Quality(5y)328.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.03%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%12.08%
EPS Next Y6.19%
EPS Next 2Y19.88%
EPS Next 3Y16.85%
EPS Next 5Y13.59%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%6.65%
Revenue Next Year8.23%
Revenue Next 2Y8.64%
Revenue Next 3Y8.27%
Revenue Next 5Y7.22%
EBIT growth 1Y13.81%
EBIT growth 3Y-5.38%
EBIT growth 5Y3.87%
EBIT Next Year20.95%
EBIT Next 3Y15.22%
EBIT Next 5Y11.27%
FCF growth 1Y-26.45%
FCF growth 3Y-6.75%
FCF growth 5Y6.9%
OCF growth 1Y-24.5%
OCF growth 3Y-6.19%
OCF growth 5Y7.14%
ABBVIE INC / 1ABBV.MI FAQ
Can you provide the ChartMill fundamental rating for ABBVIE INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1ABBV.MI.
Can you provide the valuation status for ABBVIE INC?
ChartMill assigns a valuation rating of 6 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Fairly Valued.
What is the profitability of 1ABBV stock?
ABBVIE INC (1ABBV.MI) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for 1ABBV stock?
The Price/Earnings (PE) ratio for ABBVIE INC (1ABBV.MI) is 21.29 and the Price/Book (PB) ratio is -2176.88.
Can you provide the financial health for 1ABBV stock?
The financial health rating of ABBVIE INC (1ABBV.MI) is 3 / 10.